MAHBOOB ALAM to Drug-Eluting Stents
This is a "connection" page, showing publications MAHBOOB ALAM has written about Drug-Eluting Stents.
Connection Strength
2.338
-
Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. Am J Cardiol. 2017 Nov 01; 120(9):1514-1520.
Score: 0.546
-
Use of drug-eluting stents or coronary artery bypass grafting in patients with unprotected left main coronary artery disease. Am J Cardiol. 2013 Mar 15; 111(6):921-2.
Score: 0.403
-
Unprotected left main coronary artery disease--coronary artery bypass graft versus percutaneous coronary intervention: lessons from randomized clinical trials. J Card Surg. 2013 May; 28(3):276-7.
Score: 0.380
-
Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol. 2012 May; 35(5):291-6.
Score: 0.377
-
Long-term clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery in heart transplant patients with cardiac allograft vasculopathy. Int J Cardiol. 2012 Apr 05; 156(1):101-4.
Score: 0.372
-
Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). Am J Cardiol. 2019 12 15; 124(12):1807-1812.
Score: 0.158
-
Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of =70 years. Am J Cardiol. 2013 Sep 01; 112(5):615-22.
Score: 0.102